Current Pharmaceutical Design
Title: Editorial [Hot Topic: The Administration of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Dentistry (Executive Editor: Saynur Vardar)]
Volume: 11 Issue: 14
Author(s): Saynur Vardar
Affiliation:
Export Options
About this article
Cite this article as:
Vardar Saynur, Editorial [Hot Topic: The Administration of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Dentistry (Executive Editor: Saynur Vardar)], Current Pharmaceutical Design 2005; 11 (14) . https://dx.doi.org/10.2174/1381612053764913
DOI https://dx.doi.org/10.2174/1381612053764913 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
B Cells Compartment in Centenarian Offspring and Old People
Current Pharmaceutical Design Diabetes Gene Therapy: Potential and Challenges
Current Gene Therapy Sirtuins and Resveratrol-Derived Compounds: A Model for Understanding the Beneficial Effects of the Mediterranean Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition Recent Advances in Immune Modulation
Current Gene Therapy Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine Medical Treatment of Overactive Bladder: An Overview
Current Clinical Pharmacology Peptimmunology: Immunogenic Peptides and Sequence Redundancy
Current Drug Discovery Technologies Editorial [Hot Topic: IDO1, Cancer and Cancer-Associated Inflammation (Guest Editor: Sergio Rutella)]
Current Medicinal Chemistry Microporation Techniques for Enhanced Delivery of Therapeutic Agents
Recent Patents on Drug Delivery & Formulation Emerging Roles for the CD36 Scavenger Receptor as a Potential Therapeutic Target for Corneal Neovascularization
Endocrine, Metabolic & Immune Disorders - Drug Targets Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET
Current Pharmaceutical Design Patent Selections:
Recent Patents on Biomarkers Interaction of Human Herpesvirus 8 Viral Interleukin-6 with Human Interleukin-6 Receptor Using <i>In Silico</i> Approach: The Potential Role in HHV-8 Pathogenesis
Current Proteomics Angiogenin as a Molecular Target for the Treatment of Prostate Cancer
Current Cancer Therapy Reviews “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Regulation of Eosinophil Migration and Th2 Cell Function by IL-5 and Eotaxin
Current Drug Targets - Inflammation & Allergy Antimicrobial Peptides in Burns and Wounds
Current Protein & Peptide Science Editorial [Hot Topic: Emerging Strategies for Allergen Specific Immunotherapy (Guest Editors: Prem L. Bhalla & Mohan B. Singh)]
Inflammation & Allergy - Drug Targets (Discontinued) Biotransformation of Endocrine Disrupting Compounds by Selected Phase I and Phase II Enzymes – Formation of Estrogenic and Chemically Reactive Metabolites by Cytochromes P450 and Sulfotransferases
Current Medicinal Chemistry